Criteria

Kidney Disease: Improving Global Outcomes (KDIGO) - definition criteria[1]

Any of the following:

  • Increase in serum creatinine by ≥0.3 mg/dL within 48 hours; or

  • Increase in serum creatinine to ≥1.5 times baseline, which is known or presumed to have occurred within the prior 7 days; or

  • Urine volume <0.5 mL/kg/hour for 6 hours.

Kidney Disease: Improving Global Outcomes (KDIGO) - severity criteria[1]

  • Stage 1

    • Serum creatinine 1.5 to 1.9 times baseline; or

    • ≥0.3 mg/dL increase in serum creatinine; or

    • Urine output <0.5 mL/kg/hour body weight for 6 to 12 hours

  • Stage 2

    • Creatinine increased 2.0 to 2.9 times; or

    • Urine output <0.5 mL/kg/hour for 12 hours

  • Stage 3

    • Creatinine increased 3.0 times; or

    • Increase in creatinine to ≥4.0 mg/dL; or

    • Initiation of renal replacement therapy; or

    • Urine output <0.3 mL/kg/hour for 24 hours OR anuria for 12 hours.

RIFLE (Risk, Injury, Failure, Loss of kidney function, and Endstage kidney disease) consensus criteria[89]

Laboratory test indicates reduced renal clearance.

Severity groups are as follows.

  • Indicates risk:

    • Serum creatinine increased 1.5 times; or

    • Urine production of <0.5 mL/kg body weight for 6 hours.

  • Indicates injury:

    • Creatinine increased 2.0 times; or

    • Urine production of <0.5 mL/kg for 12 hours.

  • Indicates failure:

    • Creatinine increased 3.0 times; or

    • Urine output <0.3 mL/kg for 24 hours or anuria for 12 hours.

  • Indicates loss:

    • Persistent AKI for more than 4 weeks; complete loss of kidney function.

  • Indicates ESRD:

    • ESRD (loss >3 months).

Use of this content is subject to our disclaimer